Table 2.

Summary Of Responses From The Baseline Genotyping Survey Stratified Based On National Origin Of TAILOR PCI Participants

Somewhat or Strongly Agree Response
Variable	Canada (N=381)		Korea (N=374)		USA (N=572)		p Value
It is important to me to find out if I have prescription drug-related genetic variants that might be important to my health, N (%)	345	(91%)	164	(44%)	506	(89%)	<.001
It is important to me to find out if I have other genetic variants (not related to how my body uses prescription drugs) that might be important to my health, N (%)	339	(89%)	160	(43%)	471	(82%)	<.001
In the future, I would feel comfortable if my physician recommended genetic testing to help guide my health care (if cost were not a factor), N (%)	344	(90%)	160	(43%)	497	(87%)	<.001
Not related to this trial, I would feel comfortable if my physician shared results of my genetic testing with other physicians to guide use of medications, N (%)	341	(90%)	107	(29%)	490	(86%)	<.001
Not related to this trial, I would feel comfortable if my pharmacist had access to results of my genetic testing to guide use of medications, N (%)	332	(87%)	105	(28%)	386	(68%)	<.001
Not related to this trial, I would feel comfortable if genetic testing results were available as part of my medical record, N (%)	336	(88%)	126	(34%)	444	(78%)	<.001
Not related to this trial, I would feel comfortable carrying results of my genetic testing to guide use of medications in the form of a card or on my smart phone, N (%)	322	(85%)	95	(25%)	405	(71%)	<.001
I am confident in my ability to understand information about genetics, N (%)	329	(86%)	79	(21%)	437	(77%)	<.001